A National Translational Science Network of Precision-Based Immunotherapy for Primary Liver Cancer (PLC)
Demographics (2)
- AGE - Subject age at enrollment (phv00525815.v1.p1)
- SEX - Subject's biological sex (phv00525810.v1.p1)
Other (13)
- ANALYTE_TYPE - Sample analyte type (phv00525819.v1.p1)
- APPLICATION - Type of sequencing experiment that the sample was used for (phv00525818.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00525817.v1.p1)
- COLLECTION_CENTER - Geographical location where sample was collected (phv00525822.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00525809.v1.p1)
- DISEASE - Subject's disease (phv00525814.v1.p1)
- IS_FFPE - Was the sample formalin-fixed paraffin-embedded (phv00525821.v1.p1)
- IS_TUMOR - Tumor status (phv00525820.v1.p1)
- SAMPLE_ID - Sample ID (phv00525816.v1.p1)
- SAMPLE_ID - Sample ID (phv00525812.v1.p1)
- SUBJECT_ID - Subject ID (phv00525808.v1.p1)
- SUBJECT_ID - Subject ID (phv00525813.v1.p1)
- SUBJECT_ID - Subject ID (phv00525811.v1.p1)